子宮頸がん診断検査市場は、2021年の51億4,125万米ドルから2028年までに71億6,592万米ドルに達すると予測されています。 2021 年から 2028 年にかけて 4.9% の CAGR で成長すると予想されています。
子宮頸がんは死亡率が高く (ほぼ 50%)、早期発見と予防によって死亡率を下げることができます。病気の進行が遅れることが多いため、前がん性変化は予防と治療の機会を提供します。しかし、認識や診断サービスへのアクセスが不足しているため、多くの症例は病気の進行の後期段階で発見されます。ヒトパピローマウイルス(HPV)は子宮頸がんの主な原因であり、通常は性的接触によって感染します。 HPV 株は 100 を超えており、そのうち 13 株は高リスクまたは発がん性があります。活性遺伝子 - E6 または E7 - は、HPV 株のリスクが高いか低いかを決定します。 E6 は p53 に結合し、タンパク質分解を引き起こします。一方、E7 は網膜芽細胞腫に結合します。この結合により、以前に付着していた転写因子が置き換えられ、その結果、細胞周期が停止し、アポトーシス制御が阻害されます。 HPV検査では子宮頸部の細胞からヒトパピローマウイルスを検出します。発展途上国の資源の少ない地域で採用されている他のスクリーニング手法には、HPV DNA 検査と目視検査があります。定期的な子宮頸がん検診は、子宮頸がんの早期発見に役立ち、この病気による死亡率を低下させます。 3年ごとに、21歳から65歳までのすべての女性はパップ検査を受けることが推奨され、30歳から65歳までの女性はパップ検査とHPV検査の両方を受けることが推奨されます。収益の点では、このタイプは 2021 年の子宮頸がん検診市場を支配しており、予測期間中もその優位性は続くと予想されます。
戦略的洞察
子宮頸がんにとって有利な地域診断検査市場
市場洞察がんの罹患率の増加が予測期間中の子宮頸がん診断検査市場の成長を促進
がんは、世界中で主な死因として浮上しています。世界保健機関 (WHO) によると、2019 年、がんは 70 歳未満の人々の死因の第 1 位は 183 か国であり、がんは世界 123 か国の第 4 位でした。 WHO は 2021 年 3 月に、2020 年にはさまざまな種類のがんにより約 1,000 万人が死亡したと発表しました。世界中の女性における子宮頸がんの罹患率の上昇により、子宮頸がん診断検査市場の成長が促進されています。 WHO によると、子宮頸がんによる女性の死亡は毎年 27 万人以上と記録されています。子宮頸がんの死亡率は、子宮頸がんの診断が遅れているため、低所得国でより高くなります。子宮頸がんの早期発見のための子宮頸がん診断検査の受け入れが増えているため、この市場は今後数年間で成長すると予測されています。がんの有病率の増加により、世界中の医療システムに負担がかかっています。国際がん研究機関 (IARC) によると、世界の新規がん患者数は 2040 年までに約 2,750 万人に達すると推定されており、この病気は同年までに約 1 億 6,300 万人の死亡原因となる可能性があります。ライフスタイルの変化、喫煙、身体活動の減少、不確実な健康状態や気候条件などの要因により、今後数年間で世界中でがんの負担がさらに大きくなる可能性があります。
タイプベースの洞察
子宮頸がん診断検査市場は、種類に基づいて、PAP 検査、HPV 検査、膣鏡検査、子宮頸部生検、膀胱鏡検査などに分類されます。 2021 年には、PAP 検査セグメントが市場で最大のシェアを占め、2021 年から 2028 年にかけて最高の CAGR を記録すると推定されています。
種類別の子宮頸がん診断検査市場 - 2021 年と 2028 年 サービス プロバイダーベースの洞察
サービス プロバイダーに基づいて、市場は研究、診断および研究所、病院および診療所、専門診療所、在宅ケア サービスに分類されます。 2021年には、診断および研究機関部門が市場で最大のシェアを占め、2021年から2028年にかけて市場で最高のCAGRを記録すると予想されています。子宮頸がん診断検査市場で事業を展開している企業は、製品イノベーションなどのさまざまな戦略を採用しています。
子宮頸がん診断検査市場 - セグメント化
子宮頸がん診断検査市場は次のように分類されています。タイプの基礎とサービスプロバイダー。種類に基づいて、市場は PAP 検査、HPV 検査、コルポスコピー、子宮頸部生検、膀胱鏡検査などにサブセグメント化されています。サービスプロバイダーに基づいて、市場は診断および研究機関、病院およびクリニック、専門クリニック、在宅ケアサービスにさらに分割されます。地理的には、子宮頸がん診断検査市場は、北米(米国、カナダ、メキシコ)、ヨーロッパ(フランス、ドイツ、イタリア、英国、スペイン、その他のヨーロッパ)、アジア太平洋(オーストラリア、中国、インド、日本、韓国、およびその他の APAC 地域)、中東およびアフリカ(サウジアラビア、南アフリカ、UAE およびその他の MEA 地域)、中南米(ブラジル、アルゼンチン、およびその他の SCAM 地域) ).
会社概要
- F. Hoffmann-La Roche Ltd.
- Abbott
- Quest Diagnostics Incorporated
- QIAGEN
- Hologic, Inc.
- DYSIS Medical Inc.
- Femasys Inc.
- Guided Therapeutics, Inc.
- Cooper Companies, Inc.
- BD
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Cervical Cancer refers to cancer that occurs in the cells of the cervix i.e. the lower part of the uterus that connects to the vagina. In 90% of the cases, cervical malignancies occur due to the HPV infection and are diagnosed through smear screening.
The factors that are driving and restraining factors that will affect the cervical cancer diagnostic testing market in the coming years. Factors such as the increasing prevalence of cancer and the rise in HPV infections are driving the market growth. However, less number of commercially available vaccines for the treatment of cancer are likely to hamper the growth of the market.
The cervical cancer diagnostic testing market majorly consists of the players such as as F. Hoffmann-La Roche Ltd., Abbott, Quest Diagnostics Incorporated, QIAGEN, Hologic, Inc., DYSIS Medical Inc., Femasys Inc., Guided Therapeutics, Inc, Cooper Companies, Inc., BD are amongst others.
The global cervical cancer diagnostic testing market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The North American area holds the largest market for aesthetic skin devices. The United States held the most significant cervical cancer diagnostic testing market and is expected to grow due to factors such as high awareness about disease prevention among women in the region, as well as to the many initiatives launched to prevent cervical cancer, which have increased the reach of insurance coverage for cervical screening tests, especially for low-income women, and others.
The cervical cancer diagnostic testing market based on type is segmented into PAP testing, HPV testing, colposcopy, cervical biopsies, cystoscopy, others. In 2021, the PAP Testing segment accounted for the highest share. Besides, the HPV testing segment is expected to grow at a CAGR of 5.5% in the forecast period.
Asia Pacific is registered as the fastest-growing region in the global cervical cancer diagnostic testing market. The market is this region is expected to grow significantly in countries such as China, Japan, and India. The market is driven by the increasing prevalence of cervical cancer in developing countries, including China, India, Malaysia, Japan, South Korea, and Australia.
The List of Companies - Cervical Cancer Diagnostic Testing Market
- F. HOFFMANN-LA ROCHE LTD.
- Abbott
- Quest Diagnostics Incorporated
- QIAGEN
- Hologic, Inc.
- DYSIS Medical Inc
- Femasys Inc.
- GUIDED THERAPEUTICS, INC
- Cooper Companies, Inc.
- BD
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Dec 2021
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Dec 2021
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2021
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2021
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2021
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2021
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2021
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Dec 2021
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)